237 related articles for article (PubMed ID: 29659585)
1. Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).
Kawakita N; Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Nakamura K; Ito H;
PLoS One; 2018; 13(4):e0194623. PubMed ID: 29659585
[TBL] [Abstract][Full Text] [Related]
2. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
[TBL] [Abstract][Full Text] [Related]
3. Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions - Subanalysis of a Randomized Controlled Trial.
Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Nakamura K; Ito H;
Circ J; 2018 Jun; 82(7):1788-1796. PubMed ID: 29669963
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil for Periprocedural Myocardial Injury in Elective Percutaneous Coronary Intervention: A Meta-Analysis of 10 Randomized Controlled Trials.
Yi B; Luo J; Jiang Y; Mo S; Xiao X; Chen X; Rong J
Angiology; 2020 Aug; 71(7):609-615. PubMed ID: 32295385
[TBL] [Abstract][Full Text] [Related]
5. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
[TBL] [Abstract][Full Text] [Related]
6. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
7. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Kirtane AJ; Zhang RY
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():616-23. PubMed ID: 26864270
[TBL] [Abstract][Full Text] [Related]
8. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
9. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
[TBL] [Abstract][Full Text] [Related]
11. Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials.
D'Ascenzo F; Moretti C; Omedè P; Cerrato E; Cavallero E; Er F; Presutti DG; Colombo F; Crimi G; Conrotto F; Dinicolantonio JJ; Chen S; Prasad A; Biondi Zoccai G; Gaita F
EuroIntervention; 2014; 9(12):1463-71. PubMed ID: 24755386
[TBL] [Abstract][Full Text] [Related]
12. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
[TBL] [Abstract][Full Text] [Related]
13. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
14. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
Ishibashi Y; Muramatsu T; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Cho YK; Garcia-Garcia HM; van Boven AJ; Piek JJ; Sabaté M; Helqvist S; Baumbach A; McClean D; de Sousa Almeida M; Wasungu L; Miquel-Hebert K; Dudek D; Chevalier B; Onuma Y; Serruys PW
JACC Cardiovasc Interv; 2015 Jul; 8(8):1053-1063. PubMed ID: 26205444
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention.
Shehata M
J Interv Cardiol; 2014 Oct; 27(5):472-81. PubMed ID: 25174952
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial.
Ye Z; Lu H; Su Q; Long M; Li L
Drug Des Devel Ther; 2018; 12():2591-2599. PubMed ID: 30174413
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
Zhao XT; Zhang CF; Liu QJ
BMC Cardiovasc Disord; 2019 Jun; 19(1):144. PubMed ID: 31200660
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
Chen SL; Zhang JJ; Ye F; Tian NL; Sheiban I; Jepson N; Paiboon C; Sansoto T; Kwan TW; Wen SY; Wang HC; Jiang TM; Wang Y; Chen LL; Qiu CG; Zhang YJ; Chen MX; De Maria A
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():696-705. PubMed ID: 25631678
[TBL] [Abstract][Full Text] [Related]
20. The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial.
Moretti C; Cerrato E; Cavallero E; Lin S; Rossi ML; Picchi A; Sanguineti F; Ugo F; Palazzuoli A; Bertaina M; Presbitero P; Shao-Liang C; Pozzi R; Giammaria M; Limbruno U; Lefèvre T; Gasparetto V; Garbo R; Omedè P; Sheiban I; Escaned J; Biondi-Zoccai G; Gaita F; Perl L; D'Ascenzo F
Int J Cardiol; 2018 Apr; 257():1-6. PubMed ID: 29506674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]